Efficacy and safety of intramuscular aripiprazole, haloperidol or placebo in acutely agitated patients with schizophrenia or schizoaffective disorder

被引：0
|
作者：
Oren, D [1 ]
Marcus, R [1 ]
Kostic, D [1 ]
McQuade, R [1 ]
Iwamoto, T [1 ]
Archibald, D [1 ]
机构：
[1] Bristol Myers Squibb Co, Wallingford, CT 06492 USA
来源：
SCHIZOPHRENIA BULLETIN | 2005年 / 31卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：499 / 499
页数：1
相关论文
共 50 条
  • [1] Comparison of intramuscular aripiprazole and haloperidol with placebo in acutely agitated schizophrenia patients
    Dillenschneider, A
    Oren, D
    Marcus, R
    Kostic, D
    McQuade, R
    Iwamoto, T
    Manos, G
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S509 - S509
  • [2] Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder
    Kane, JM
    Carson, WH
    Saha, AR
    McQuade, RD
    Ingenito, GG
    Zimbroff, DL
    Ali, MW
    JOURNAL OF CLINICAL PSYCHIATRY, 2002, 63 (09) : 763 - 771
  • [3] Intramuscular aripiprazole for the treatment of acute agitation in patients with schizophrenia or schizoaffective disorder: a double-blind, placebo-controlled comparison with intramuscular haloperidol
    Andrezina, Raisa
    Josiassen, Richard C.
    Marcus, Ronald N.
    Oren, Dan A.
    Manos, George
    Stock, Elyse
    Carson, William H.
    Iwamoto, Taro
    PSYCHOPHARMACOLOGY, 2006, 188 (03) : 281 - 292
  • [4] Intramuscular aripiprazole for the treatment of acute agitation in patients with schizophrenia or schizoaffective disorder: a double-blind, placebo-controlled comparison with intramuscular haloperidol
    Raisa Andrezina
    Richard C. Josiassen
    Ronald N. Marcus
    Dan A. Oren
    George Manos
    Elyse Stock
    William H. Carson
    Taro Iwamoto
    Psychopharmacology, 2006, 188 : 281 - 292
  • [5] PLACID study: A randomized trial comparing the efficacy and safety of inhaled loxapine versus intramuscular aripiprazole in acutely agitated patients with schizophrenia or bipolar disorder
    San, Luis
    Estrada, Gemma
    Oudovenko, Natalia
    Montanes, Francisco
    Dobrovolskaya, Natalia
    Bukhanovskaya, Olga
    Popov, Mikhail
    Vieta, Eduard
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2018, 28 (06) : 710 - 718
  • [6] Intramuscular olanzapine versus intramuscular haloperidol and intramuscular placebo: An international double-blind study in acutely agitated patients with schizophrenia
    David, SR
    Meehan, K
    Birkett, MA
    Wright, P
    Ferchland, I
    Alaka, K
    Brook, S
    SCHIZOPHRENIA RESEARCH, 2001, 49 (1-2) : 224 - 224
  • [7] A naturalistic comparison of the efficacy and safety of intramuscular olanzapine and intramuscular haloperidol in agitated elderly patients with schizophrenia
    Suzuki, Hidenobu
    Gen, Keishi
    Takahashi, Yuki
    THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2013, 3 (06) : 314 - 321
  • [8] Efficacy and safety of aripiprazole and haloperidol in patients with schizophrenia
    Sulejmanpasic-Arslanagic, G.
    Kapetanovic, D.
    Srebrenka, B.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S490 - S491
  • [9] Non-inferiority of intramuscular aripiprazole versus intramuscular haloperidol for the treatment of agitation associated with schizophrenia/schizoaffective disorder
    Oren, D. A.
    Marcus, R. N.
    Manos, G.
    Carson, W. H.
    McQuade, D.
    SCHIZOPHRENIA BULLETIN, 2007, 33 (02) : 451 - 451
  • [10] A naturalistic comparison study of the efficacy and safety of intramuscular olanzapine, intramuscular haloperidol, and intramuscular levomepromazine in acute agitated patients with schizophrenia
    Suzuki, Hidenobu
    Gen, Keishi
    Takahashi, Yuki
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2014, 29 (01) : 83 - 88
12345